8-K
filed January 27, 2023, 6:59 PM ET
ticker FHI
CIK 0001056288
earnings
confidence high
sentiment negative
materiality 0.75
Federated Hermes Q4 EPS $0.63 (incl. $0.27 impairment); record AUM $668.9B
FEDERATED HERMES, INC.
2022-FY EPS reported
$2.65
revenue$1,445,814,000
- Q4 2022 EPS $0.63, net income $56.5M; FY EPS $2.65 vs $2.75 in 2021.
- Total AUM $668.9B record, up $28M YoY and 7% QoQ from $624.4B.
- Board declares $0.27 quarterly dividend payable Feb 15, record Feb 8.
- Q4 includes $31.5M non-cash impairment charge ($0.27/share) from Hermes acquisition.
- Money market assets record $476.8B; equity assets down 16% YoY to $81.5B.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
FEDERATED HERMES, INC. reported full-year 2022 results: net income net income of $239.5 million for 2022, EPS Full-year 2022 EPS was $2.65.
- Period
- full-year 2022
- Net income
- net income of $239.5 million for 2022
- EPS
- Full-year 2022 EPS was $2.65
- Result
- reported results
Exact text from the filing
Full-year 2022 EPS was $2.65, compared to $2.75 for 2021 on net income of $239.5 million for 2022, compared to $270.3 million for 2021
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
FEDERATED HERMES, INC. reported fourth quarter 2022 results: net income net income of $56.5 million for Q4 2022, EPS earnings per diluted share (EPS) for Q4 2022 of $0.63.
- Period
- fourth quarter 2022
- Net income
- net income of $56.5 million for Q4 2022
- EPS
- earnings per diluted share (EPS) for Q4 2022 of $0.63
- Result
- reported results
Exact text from the filing
Federated Hermes, Inc. reports fourth quarter and full-year 2022 earnings • Q4 2022 earnings per diluted share of $0.63; full-year 2022 EPS of $2.65, each including a ($0.27) per diluted share non-cash intangible asset impairment charge
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.